BioNTech SE Current Trade Receivables
BioNTech SE (BNTX) had Current Trade Receivables of EUR 2.16 billion as of 2023-12-31, per its 20-F filed 2024-03-20.
Discontinued › Notes › Receivables
ifrs-full:CurrentTradeReceivables · last filed 2024-03-20
- 2023-12-31: Current Trade Receivables 2.16B EUR.
- 2022-12-31: Current Trade Receivables 7.15B EUR.
- 2021-12-31: Current Trade Receivables 12.38B EUR.
- 2020-12-31: Current Trade Receivables 165.50M EUR; Current Trade Receivables as first filed 165.47M EUR.
| Period end | Current Trade Receivables | Current Trade Receivables as first filed |
|---|---|---|
| 2023-12-31 | 2.16B EUR 20-F · filed 2024-03-20 | |
| 2022-12-31 | 7.15B EUR 20-F · filed 2024-03-20 | |
| 2021-12-31 | 12.38B EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 165.50M EUR 20-F/A · filed 2022-10-26 | 165.47M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 11.91M EUR 20-F · filed 2021-03-30 | |
| 2018-12-31 | 18.94M EUR 20-F · filed 2020-03-31 |